AI assisted tool linked to improved stroke care and outcomes

Offers a more efficient and scalable method for improving stroke care and prognosis, say researchers A clinical decision support tool that uses artificial intelligence (AI) to analyse scans after a stroke alongside treatment recommendations is associated with better quality care and long term outcomes for patients compared with usual care, ...

2026-03-23T11:51:06+00:0023 March 2026|Press release, The BMJ|

Stimulating international research dialogue on SGLT2 inhibitors and immune risk

The BMJ research: sodium-glucose cotransporter-2 inhibitors and risk of autoimmune rheumatic diseases In October 2025, The BMJ published the first nationwide population based cohort study to examine the association between sodium-glucose cotransporter-2 (SGLT2) inhibitors and risk of autoimmune rheumatic diseases (ARDs). Drawing on data from more than ...

2026-03-03T15:55:24+00:0027 February 2026|Group news, Our impact, Success stories, The BMJ|
Go to Top